Plastic Surgery

doi: 10.25005/2074-0581-2021-23-2-208-215
THE EFFECT OF THE MENSTRUAL CYCLE PHASE ON THE OUTCOME OF AUGMENTATION MAMMOPLASTY

T.R. Fayzullin

M.F. Vladimirsky Moscow Regional Research and Clinical Institute, Moscow, Russian Federation

Objective: To determine the optimal timing for augmentation mammoplasty (AM) relative to the menstrual cycle phase.

Methods: The results of 49 cases of AM performed at different phases of the menstrual cycle were analyzed. The study period was 1 year. The patients were divided into 4 groups depending on the phase of the menstrual cycle: follicular phase during menstruation, follicular phase after menstruation; ovulation; luteal phase. The results were reviewed for intra- and postoperative complications.

Results: Patients operated during different phases of menstrual cycle showed significantly different rate of intra- and postoperative complications, such as implant cavity drainage, early hematomas, increased tissue edema and prolonged rehabilitation. Luteal phase of the menstrual cycle was shown to be more favorable for AM with lower risk of complications in the early postoperative period.

Conclusion: During planning of AM the phase of menstrual cycle should be considered to reduce the risk of intra- and postoperative complications and provide better outcome of AM.

Keywords: Augmentation mammoplasty, implant cavity drainage, early hematomas, increased tissue edema, prolonged rehabilitation, menstrual cycle phase.

Download file:


References
  1. Khodzhamurodova DA, Saidov MS, Khodzhamuradov GM. Primenenie silikonovykh implantov v plasticheskoy khirurgii molochnykh zhelyoz [The use of silicone implants in plastic surgery of the mammary glands]. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika I.P. Pavlova. 2018;26(1):133-49.
  2. Shen Z, Chen X, Sun J, Chiu C, Yu Y, Lin X, et al. A comparative assessment of three planes of implant placement in breast augmentation: A Bayesian analysis. J Plast Reconstr Aesthet Surg. 2019;72(12):1986-95.
  3. Kairov GT, Klimenkova VF, Tyutrin II, Udut VV. Gemostaticheskiy potentsial tsel’noy krovi v dinamike normal’nogo menstrual’nogo tsikla zdorovykh zhenshchin [Hemostatic potential of whole blood in the dynamics of the normal menstrual cycle in healthy women]. Buylleten’ meditsinskikh Internet-konferentsiy. 2016;6(8):1418-20.
  4. Handel N, Cordray T, Gutierrez J, Jensen JA. A longterm study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg. 2006;117(3):75767.
  5. Steiert AE, Boyce M, Sorg H. Capsular contracture by silicone breast implants: Possible causes, biocompatibility, and prophylactic strategies. Med Devices. 2013;6:2118.
  6. Malikov MKh, Karimzade GD, Saidov IS, Jononov JD, Makhmadkulova NA. Korrektsiya posleozhogovoy rubtsovoy deformatsii molochnoy zhelezy [Correction of burn scarring deformity in mammary gland]. Vestnik poslediplomnogo obrazovaniya v sfere zdravookhraneniya. 2020;1:98-104.
  7. Calobrace MB, Stevens WG, Capizzi PJ, Cohen R, Godinez T, Beckstrand M. Risk factor analysis for capsular contracture: A 10-year Sientra study using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg. 2018;141:20-8.
  8. McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg. 2017;139:1-9.
  9. Shustov A, Soma L. Anaplastic large cell lymphoma: Contemporary concepts and optimal management. Cancer Treat Res. 2019;176:127-144.
  10. Ovechkin AM. Bol’ i plasticheskaya khirurgiya: kak izbezhat’ problem na puti k sovershenstvu [Pain and plastic surgery: how to avoid problems on the path to excellence]. Klinicheskaya i eksperimentalnaya khirurgiya. 2016;4(3):51-63.
  11. Levakov SA, Borovkova EI. Bol’ v molochnoy zheleze: differentsirovannyy podkhod k vedeniyu patsientok [Breast pain: a differentiated approach to patient management]. Consilium Medicum. 2016;18(6):74-6.
  12. Plaksin SA. Pozdnie seromy posle endoprotezirovaniya molochnykh zhelyoz [Late seromas after breast augmentation]. Annaly plasticheskoy, rekonstruktivnoy i esteticheskoy khirurgii. 2018;4:114.
  13. Shumakova TA, Savello VE. Vozmozhnosti MRT v diagnostike serom posle augmentatsionnoy mammoplastiki silikonovymi gelevymi implantatami [Possibilities of MRI in the diagnosis of seroma after augmentation mammoplasty with silicone gel implants]. Meditsinskaya vizualizatsiya. 2014;4:132-41.
  14. Rankati A, Nava M, Tessari L. Augmentatsionnaya mammoplastika v sochetanii s periolyarnoy mastopeksiey: vybor pravil’nogo implantanta [Augmentation mammoplasty in combination with periareolar mastopexy: choosing the right implant]. Plasticheskaya khirurgiya i kosmetologiya. 2012;2:203-8
  15. Shchepotin IB, Zotov AS, Lyubota RV, Anikusko NF, Lyubota II. Kompleksnyy analiz faktorov, vliyayushchikh na dlitel’nost’ sushchestvovaniya podkozhnykh serom posle khirurgicheskogo lecheniya bol’nykh rakom molochnoy zhelezy [Complex analysis of factors influencing the duration of subcutaneous seromas existence after surgical treatment of patients with breast cancer]. Opukholi zhenskoy reproduktivnoy sistemy. 2014;2:37-40.
  16. Huang GJ, Wichmann JL, Mills DC. Transaxillary subpectoral augmentation mammaplasty: A single surgeon’s 20-year experience. Aesthet Surg J. 2011;31(7):781-801.
  17. Namnoum JD, Largent J, Kaplan HM, Oefelein MG, Brown MH. Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg. 2013;66(9):116572.

Author information:


Fayzullin Tagir Rishatovich
Candidate of Medical Sciences, Associate Professor, Course of Plastic Surgery, M.F. Vladimirsky Moscow Regional Research and Clinical Institute
ORCID ID: 0000-0002-3972-7448
SPIN: 7413-3260,
Author ID: 872749
E-mail: tagir@dr-fayzullin.ru

Information about support in the form of grants, equipment, medications

The author did not receive financial support from companies manufacturing medications and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Fayzullin Tagir Rishatovich
Candidate of Medical Sciences, Associate Professor, Course of Plastic Surgery, M.F. Vladimirsky Moscow Regional Research and Clinical Institute

129110, Russian Federation, Moscow, 61/2 Shchepkina str.

Tel: +7 (985) 3602110

E-mail: tagir@dr-fayzullin.ru

Materials on the topic: